Who are the Key Players in the Global Coronavirus Vaccine Market ?

Key Players of coronavirus vaccine market are I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax,

Coronavirus Vaccine Market Share, Size, Growth and Forecast to 2031

Q: What is the CAGR of Global Coronavirus Vaccine Market ?

The Coronavirus Vaccine Market is expected to grow at a -25.0 % CAGR during the forecast period for 2023-2031.

The Coronavirus Vaccine Market is expected to grow at a -25.0 % CAGR during the forecast period for 2023-2031.

Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market during the forecast period.

Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19 vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.

Market Segmentation

The Coronavirus Vaccine Market can be segmented on the basis of Infection Type, Vaccine Type, End-Users, and region. On the basis of Infection Type, the market can be divided into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV. SARS-CoV segment is expected to dominate the market as this virus is the main reason of covid-19 outbreak. On the basis of Vaccine Type, the market can be segmented into Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine. In terms of End-Users, market is divided into Hospitals, Clinics, Research Institutes, and Others. On the basis of region, the market is segmented into the North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the coronavirus vaccine market in the coming future.

Competitive Landscape

Some of The Key Players in The Coronavirus Vaccine Market:

I-Mab Biopharma
Medicago
Airway Therapeutics
Tiziana Life Sciences
Inovio Pharmaceuticals
Novavax, Inc
Moderna
AstraZeneca
Pfizer
Johnson &Johnson
GlaxoSmithKline
Bharath Biotech
Serum Institute of India
Sinopharm
AnGes
AIVITABiomedical
CanSinoBio
eubiologics
Genexine
GreenLight Bioscience
Gennova
Heat Biologics
INOVIO
IIBR
medicago
Symvivo
Valneva
Zydus Cadila
CODAGENIX Inc.
Other Prominent Players

The Coronavirus Vaccine Market Report Scope

Report Attribute	Specifications
Growth Rate CAGR	CAGR of -25.0 % from 2023 to 2031
Quantitative Units	Representation of revenue in US$ Billion and CAGR from 2023 to 2031
Historic Year	2019 to 2022
Forecast Year	2023-2031
Report Coverage	The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered	By Infection Type, By Vaccine Type, By End-Users
Regional Scope	North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope	U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape	I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Others
Customization Scope	Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods	Explore pricing alternatives that are customized to your particular study requirements.